ICD-10 Coding for Immunoglobulin A Glomerulonephritis(D69.0, D69.0P, N02.8)
Learn about ICD-10 coding for Immunoglobulin A Glomerulonephritis, including specific codes for different glomerular lesions and documentation requirements.
Complete code families applicable to Immunoglobulin A Glomerulonephritis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N02.B1 | IgA nephropathy with minimal change disease | Use when biopsy confirms minimal change disease with IgA deposits. |
|
| N02.B3 | IgA nephropathy with diffuse membranoproliferative glomerulonephritis | Use when biopsy confirms diffuse membranoproliferative GN with IgA deposits. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutImmunoglobulin A Glomerulonephritis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Immunoglobulin A Glomerulonephritis.
Vague documentation of nephritis
Impact
Clinical: Potential misdiagnosis and inappropriate treatment., Regulatory: Failure to meet documentation standards., Financial: Denied claims due to lack of specificity.
Mitigation
Ensure biopsy details are included in documentation., Use specific terminology for glomerular lesions.
Using N02.8 instead of specific N02.Bx codes
Impact
Reimbursement: Incorrect DRG assignment leading to potential underpayment., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Inaccurate clinical data affecting patient management.
Mitigation
Query provider for specific glomerular lesion type per biopsy.
Specificity of coding
Impact
Risk of using non-specific codes for IgA nephropathy.
Mitigation
Ensure biopsy reports are detailed and specific codes are used.